Skip to main content

1 Result(s)

within J. C. D'Aoust Remove this filter

and

  1. No Access

    Article

    Dibromodulcitol plus bleomycin compared with bleomycin alone in head and neck cancer

    Advanced recurrent squamous cell head and neck cancer patients were prospectively randomized to receive or not receive dibromodulcitol 10 mg/kg PO weekly for 8 consecutive weeks in addition to bleomycin chemot...

    B. F. Issell, G. Borsos, J. C. D'Aoust, F. Banhidy… in Cancer Chemotherapy and Pharmacology (1982)